Ignite Creation Date:
2024-05-06 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03677401
Status:
COMPLETED
Last Update Posted:
2021-05-20
First Post:
2018-09-17
Brief Title:
Study of the Efficacy Safety and Tolerability of Serlopitant for the Treatment of Pruritus Itch With Prurigo Nodularis
Sponsor:
Vyne Therapeutics Inc
Organization:
Vyne Therapeutics Inc
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Study of the Efficacy Safety and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis
Status:
COMPLETED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study of the efficacy safety and tolerability of serlopitant for the treatment of pruritus in adults with prurigo nodularis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2017-004210-25 | EUDRACT_NUMBER | None | None |